Bertrand le Bourdonnec

Bertrand Le Bourdonnec is a highly experienced professional in the field of medicinal chemistry and pharmaceutical sciences, currently serving as the Chief Scientific Officer at HDAX Therapeutics since December 2023, following a period as a Scientific Advisor. Prior roles include Vice President of Chemistry, Pharmaceutical, and PreClinical Sciences at Deciphera Pharmaceuticals from May 2020 to July 2023, and Senior Vice President of Chemistry, Program Management, and Pharmaceutical Operations at Yumanity Therapeutics from July 2015 to May 2020. Bertrand also held notable positions at Cubist Pharmaceuticals, Adolor Corporation, and began a research career as a Research Fellow in the Chemistry Department. Educational qualifications include a Post-Doctoral Research Associate degree in Medicinal Chemistry from the University of Minnesota and a Project Leadership Certificate from Cornell University.